Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined IV and Topical TXA in Major Multilevel Spine Surgery
NCT04797156Phase 1Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Mar 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of tranexamic acid (3 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Change in Hematocrit level. Started Mar 2021; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04797156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797156.